Employing over 1,700 personnel and operating in 12 countries, the TBS Group is already serving 38,000 users with telecare and telehealth services.

TBS GB focuses its telehealth and telecare services on the provision of care for long-term medical conditions, including Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD), diabetes and asthma through an in-house developed innovative disease management programme.

The service comprises of state-of-the-art telehealth equipment and call centre intervention. It promotes support to local authorities, residential care facilities and hospitals with a view to enable patients and older people to live safely and in improved health and environmental conditions.

TBS GB's telehealth programme will improve quality and contain costs, by offering enhanced care delivery to people within their home. Within the reviewed National Framework Agreement we are offering advanced telehealth products for patient monitoring. We offer stand-alone systems for measuring ECG, weight, blood pressure, spirometry, pulse oximetry, blood glucose and blood coagulation (INR).

All devices are bundled with software packages, which allow healthcare operators to analyse the data and set up complete patient records necessary to manage chronic diseases. Patient data is accessible to clinicians through a standard web browser. Healthcare professionals can view the results of the measurements, monitor developing trends, receive alerts to their mailbox or mobile phone and intervene when necessary.